EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Hypertrophic Cardiomyopathy: Genes and Mechanisms

Jinli Chen, Yang Xing, Jie Sun, Yongming Liu, Zekun Lang, Lei Zhang, Jinggang Yang

Frontiers in Bioscience-Landmark · 2025

DOI: 10.31083/fbl25714 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience-Landmark, 2025. Verfasst von Jinli Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatric Medicine, First Hospital of Lanzhou University, 730000 Lanzhou, Gansu, China. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research and Development Programme of Gansu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertrophic cardiomyopathy (HCM) is a hereditary disease of the myocardium characterized by asymmetric hypertrophy (mainly the left ventricle) not caused by pressure or volume load. Most cases of HCM are caused by genetic mutations, particularly in the gene encoding cardiac myosin, such as MYH7, TNNT2, and MYBPC3. These mutations are usually inherited autosomal dominantly. Approximately 30–60% of HCM patients have a family history of similar cases among their immediate relatives. This underscores the significance of genetic factors in the development of HCM. Therefore, we summarized the gene mutation mechanisms associated with the onset of HCM and potential treatment directions. We aim to improve patient outcomes by increasing doctors’ awareness of genetic counseling, early diagnosis, and identification of asymptomatic patients. Additionally, we offer valuable insights for future research directions, as well as for early diagnosis and intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiomyopathy, HypertrophicHumansMutationCardiac MyosinsCarrier ProteinsMyosin Heavy ChainsGenetic Predisposition to DiseaseTroponin TMyosin Binding Protein C

Stichwörter der Autor:innen

cardiomyopathygenetic mutationsheredityhypertrophic cardiomyopathy

Substanzen

Cardiac MyosinsCarrier ProteinsMyosin Heavy ChainsTroponin TMyosin Binding Protein CMYH7 protein, human

Autor:innen und Institutionen

  • Department of Geriatric Medicine, First Hospital of Lanzhou University, 730000 Lanzhou, Gansu, China.
  • Gansu Provincial Clinical Medical Research Center for Geriatric Diseases, 730000 Lanzhou, Gansu, China.
  • Department of Anesthesia and Surgery, First Hospital of Lanzhou University, 730000 Lanzhou, Gansu, China.
  • The First Clinical Medical College of Lanzhou University, 730000 Lanzhou, Gansu, China.

Förderung

  • Key Research and Development Programme of Gansu Province

Zitieren

APA

Chen, J., Xing, Y., Sun, J., Liu, Y., Lang, Z., Zhang, L., & Yang, J. (2025). Hypertrophic Cardiomyopathy: Genes and Mechanisms. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl25714

Vancouver

Chen J, Xing Y, Sun J, Liu Y, Lang Z, Zhang L, et al. Hypertrophic Cardiomyopathy: Genes and Mechanisms. Frontiers in Bioscience-Landmark. 2025. doi:10.31083/fbl25714

BibTeX
@article{Chen2025,
  author = {Chen, Jinli and Xing, Yang and Sun, Jie and Liu, Yongming and Lang, Zekun and Zhang, Lei and Yang, Jinggang},
  title = {Hypertrophic Cardiomyopathy: Genes and Mechanisms},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2025},
  doi = {10.31083/fbl25714}
}
Kostenlos starten →